TR200201023T2 - Benzodiazepin türevleri. - Google Patents

Benzodiazepin türevleri.

Info

Publication number
TR200201023T2
TR200201023T2 TR2002/01023T TR200201023T TR200201023T2 TR 200201023 T2 TR200201023 T2 TR 200201023T2 TR 2002/01023 T TR2002/01023 T TR 2002/01023T TR 200201023 T TR200201023 T TR 200201023T TR 200201023 T2 TR200201023 T2 TR 200201023T2
Authority
TR
Turkey
Prior art keywords
halo
halogen
lower alkyl
optionally substituted
lower alkoxy
Prior art date
Application number
TR2002/01023T
Other languages
English (en)
Inventor
Adam Geo
Alanine Alexander
Goetschi Erwin
Mutel Vincent
Johannes Woltering Thomas
Original Assignee
F. Hoffmann-La Roche Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F. Hoffmann-La Roche Ag filed Critical F. Hoffmann-La Roche Ag
Publication of TR200201023T2 publication Critical patent/TR200201023T2/tr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/12—1,5-Benzodiazepines; Hydrogenated 1,5-benzodiazepines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Abstract

Mevcut bulus, X' in tekli bir bag veya bir etinediil grubu, X' in tekli bir bag olmasi durumunda R1' in halojen veya istege göre halojen, alt alkil, halo-alt alkil, alt alkoksi, halo-alt alkoksi veya siyano ile ikame edilen fenil oldugu; X' in bir etinediil grubu olmasi durumunda R' in istege göre halojen, alt alkil, halo-alt alkil, alt sikloalkil, alt alkoksi veya halo-alt alkoksi ile ikame edilen fenil oldugu ; R3' ün istege göre ikame edilen 5 veya 6 üyeli aril veya heteroaril oldugu genel formül (I)' e ait bilesiklerle ilgilidir.
TR2002/01023T 1999-10-15 2000-09-29 Benzodiazepin türevleri. TR200201023T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP99120520 1999-10-15

Publications (1)

Publication Number Publication Date
TR200201023T2 true TR200201023T2 (tr) 2002-09-23

Family

ID=8239207

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2002/01023T TR200201023T2 (tr) 1999-10-15 2000-09-29 Benzodiazepin türevleri.

Country Status (35)

Country Link
US (1) US6407094B1 (tr)
EP (1) EP1224174B1 (tr)
JP (1) JP3857138B2 (tr)
KR (1) KR100480320B1 (tr)
CN (1) CN1195522C (tr)
AR (1) AR026029A1 (tr)
AT (1) ATE250039T1 (tr)
AU (1) AU774451B2 (tr)
BR (1) BR0014859A (tr)
CA (1) CA2386974C (tr)
CO (1) CO5261604A1 (tr)
CZ (1) CZ20021653A3 (tr)
DE (1) DE60005386T2 (tr)
DK (1) DK1224174T3 (tr)
EG (1) EG24079A (tr)
ES (1) ES2204704T3 (tr)
GC (1) GC0000263A (tr)
HK (1) HK1051038A1 (tr)
HR (1) HRP20020259A2 (tr)
HU (1) HUP0203142A3 (tr)
IL (2) IL148816A0 (tr)
JO (1) JO2262B1 (tr)
MA (1) MA26831A1 (tr)
MY (1) MY125540A (tr)
NO (1) NO327817B1 (tr)
NZ (1) NZ517999A (tr)
PE (1) PE20010681A1 (tr)
PL (1) PL357418A1 (tr)
PT (1) PT1224174E (tr)
RU (1) RU2259360C2 (tr)
SI (1) SI1224174T1 (tr)
TR (1) TR200201023T2 (tr)
WO (1) WO2001029011A2 (tr)
YU (1) YU26202A (tr)
ZA (1) ZA200202544B (tr)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ518037A (en) 1999-10-15 2004-04-30 F Benzodiazepine derivatives useful as metabotropic glutamate receptors
YU79003A (sh) * 2001-04-12 2006-05-25 F. Hoffmann-La Roche Ag. Derivati dihidro-benzo/b/ /1,4/diazepin-2-ona kao mglur2 antagonisti ii
RU2270197C2 (ru) 2001-04-12 2006-02-20 Ф.Хоффманн-Ля Рош Аг ПРОИЗВОДНЫЕ ДИГИДРОБЕНЗО[b][1,4]ДИАЗЕПИН-2-ОНА В КАЧЕСТВЕ АНТАГОНИСТОВ I mGluR2
US20070122353A1 (en) 2001-05-24 2007-05-31 Hale Ron L Drug condensation aerosols and kits
US20030051728A1 (en) 2001-06-05 2003-03-20 Lloyd Peter M. Method and device for delivering a physiologically active compound
US6949542B2 (en) * 2002-02-06 2005-09-27 Hoffman-La Roche Inc. Dihydro-benzo[b][1,4]diazepin-2-one derivatives
EP1539149B1 (en) * 2002-09-10 2012-01-04 Novartis AG Combinations of metabotropic glutamate receptor antagonists and their use in treating addictive disorders
US20040234914A1 (en) 2003-05-21 2004-11-25 Alexza Molecular Delivery Corporation Percussively ignited or electrically ingnited self-contained heating unit and drug-supply unit employing same
JP5005343B2 (ja) * 2003-07-25 2012-08-22 エフ．ホフマン−ラ ロシュ アーゲー 急性及び／又は慢性神経障害の治療のためのｍＧｌｕＲ２アンタゴニストとＡＣｈＥインヒビターの併用
FR2862969A1 (fr) * 2003-11-28 2005-06-03 Oreal Procede de preparation de derives paraphenylenediamine a groupement pyrrolidinyle, substitue par un radical azote, et composes intermediaires
DE102004010893A1 (de) * 2004-03-06 2005-09-22 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue ß-Ketoamid-Verbindungen mit MCH-antagonistischer Wirkung und diese Verbindungen enthaltende Arzneimittel
ATE400557T1 (de) 2004-11-05 2008-07-15 Hoffmann La Roche Verfahren zur herstellung von isonikotinsäurederivaten
AP2007004047A0 (en) 2005-01-20 2007-06-30 Pfizer Ltd Substituted triazole derivatives as oxtocin antagonists
AR059898A1 (es) * 2006-03-15 2008-05-07 Janssen Pharmaceutica Nv Derivados de 3-ciano-piridona 1,4-disustituida y su uso como moduladores alostericos de los receptores mglur2
TW200900065A (en) 2007-03-07 2009-01-01 Janssen Pharmaceutica Nv 3-cyano-4-(4-pyridinyloxy-phenyl)-pyridin-2-one derivatives
TW200845978A (en) 2007-03-07 2008-12-01 Janssen Pharmaceutica Nv 3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives
US20080216828A1 (en) 2007-03-09 2008-09-11 Alexza Pharmaceuticals, Inc. Heating unit for use in a drug delivery device
WO2008128889A1 (en) * 2007-04-19 2008-10-30 F. Hoffmann-La Roche Ag Dihydro-benzo[b][1,4]diazepin-2-one sulfonamide derivatives
JP5133416B2 (ja) 2007-09-14 2013-01-30 オルソー−マクニール−ジャンセン ファーマシューティカルズ， インコーポレイテッド． １’，３’−二置換−４−フェニル−３，４，５，６−テトラヒドロ−２ｈ，１’ｈ−［１，４’］ビピリジニル−２’−オン
US8722894B2 (en) * 2007-09-14 2014-05-13 Janssen Pharmaceuticals, Inc. 1,3-disubstituted-4-phenyl-1H-pyridin-2-ones
TW200922566A (en) 2007-09-14 2009-06-01 Ortho Mcneil Janssen Pharm 1,3 disubstituted 4-(aryl-X-phenyl)-1H-pyridin-2-ones
EP2197274A4 (en) * 2007-09-26 2013-03-06 Sinai School Medicine AZACYTIDINE ANALOGS AND USES THEREOF
WO2009062676A2 (en) * 2007-11-14 2009-05-22 Ortho-Mcneil-Janssen Pharmaceuticals, Inc. Imidazo[1,2-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
US8691849B2 (en) 2008-09-02 2014-04-08 Janssen Pharmaceuticals, Inc. 3-azabicyclo[3.1.0]hexyl derivatives as modulators of metabotropic glutamate receptors
EP2346505B1 (en) 2008-10-16 2014-04-23 Janssen Pharmaceuticals, Inc. Indole and benzomorpholine derivatives as modulators of metabotropic glutamate receptors
WO2010060589A1 (en) 2008-11-28 2010-06-03 Ortho-Mcneil-Janssen Pharmaceuticals, Inc. Indole and benzoxazine derivatives as modulators of metabotropic glutamate receptors
EP2430031B1 (en) 2009-05-12 2013-04-17 Janssen Pharmaceuticals, Inc. 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
MY153913A (en) 2009-05-12 2015-04-15 Janssen Pharmaceuticals Inc 7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
US8937060B2 (en) 2009-05-12 2015-01-20 Janssen Pharmaceuticals, Inc. 1,2,4-triazolo [4,3-A] pyridine derivatives and their use for the treatment of prevention of neurological and psychiatric disorders
CN101891706B (zh) * 2010-04-09 2013-05-29 复旦大学 3,4-二氢苯并[f][1,4]噻氮杂*类化合物或其盐及其药物用途
JPWO2012015024A1 (ja) 2010-07-29 2013-09-12 大正製薬株式会社 エチニル−ピラゾール誘導体
WO2012062750A1 (en) 2010-11-08 2012-05-18 Janssen Pharmaceuticals, Inc. 1,2,4-TRIAZOLO[4,3-a]PYRIDINE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS
AU2011328195B2 (en) 2010-11-08 2015-04-02 Janssen Pharmaceuticals, Inc. 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors
AU2011328203B2 (en) 2010-11-08 2015-03-19 Janssen Pharmaceuticals, Inc. 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors
JP2012153674A (ja) * 2011-01-28 2012-08-16 Astellas Pharma Inc ジ（アリールアミノ）アリール化合物の製造方法及びその合成中間体
AU2013336863A1 (en) 2012-10-23 2015-03-19 F. Hoffmann-La Roche Ag MGlu2/3 antagonists for the treatment of autistic disorders
JO3368B1 (ar) 2013-06-04 2019-03-13 Janssen Pharmaceutica Nv مركبات 6، 7- ثاني هيدرو بيرازولو [5،1-a] بيرازين- 4 (5 يد)- اون واستخدامها بصفة منظمات تفارغية سلبية لمستقبلات ميجلور 2
JO3367B1 (ar) 2013-09-06 2019-03-13 Janssen Pharmaceutica Nv مركبات 2،1، 4- ثلاثي زولو [3،4-a] بيريدين واستخدامها بصفة منظمات تفارغية موجبة لمستقبلات ميجلور 2
IL279202B2 (en) 2014-01-21 2023-09-01 Janssen Pharmaceutica Nv Combinations containing positive allosteric modulators or orthosteric agonists of metabotropic glutamatergic subtype 2 receptor and their use
PL3431106T3 (pl) 2014-01-21 2021-06-28 Janssen Pharmaceutica Nv Kombinacje zawierające pozytywne modulatory allosteryczne metabotropowego receptora glutaminergicznego podtypu 2 i ich zastosowanie
US9895324B2 (en) 2014-03-26 2018-02-20 University Of Kentucky Research Foundation Halogenated diarylacetylenes and methods of treating cancer
KR20160143853A (ko) 2014-04-23 2016-12-14 에프. 호프만-라 로슈 아게 지적 장애의 치료를 위한 mglu2/3 길항제
EP3154954B1 (en) 2014-06-10 2022-02-09 Sanford-Burnham Medical Research Institute Metabotropic glutamate receptor negative allosteric modulators (nams) and uses thereof
CN106243050B (zh) * 2016-08-10 2019-09-06 安徽恒星制药有限公司 一种适合工业化生产氯巴占的方法
CN109836356B (zh) * 2017-11-24 2022-03-08 沈阳化工研究院有限公司 一种芳甲醚衍生物及其应用
RU2702358C1 (ru) * 2019-06-04 2019-10-08 Федеральное государственное бюджетное научное учреждение Уфимский федеральный исследовательский центр Российской академии наук Способ получения 2,2,4-триалкил-2,3-дигидро-1Н-1,5-бензодиазепинов
CN114349779B (zh) * 2021-12-29 2023-09-26 智仑超纯环氧树脂(西安)有限公司 一种改性二氧化硅颗粒除氯剂及其制备方法及应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997005109A1 (en) * 1995-07-31 1997-02-13 Novo Nordisk A/S Heterocyclic compounds, their preparation and use
MXPA00004940A (es) * 1997-11-21 2002-10-17 Nps Pharma Inc Antagonistas de receptor de glutamato metabotropico para tratar enfermedades del sistema nervioso central.

Also Published As

Publication number Publication date
NO20021690L (no) 2002-04-10
AU7910200A (en) 2001-04-30
ZA200202544B (en) 2003-09-23
US6407094B1 (en) 2002-06-18
DK1224174T3 (da) 2004-01-26
PE20010681A1 (es) 2001-06-28
CA2386974C (en) 2009-10-13
CN1195522C (zh) 2005-04-06
GC0000263A (en) 2006-11-01
EG24079A (en) 2008-05-11
PT1224174E (pt) 2004-01-30
CA2386974A1 (en) 2001-04-26
WO2001029011A3 (en) 2001-11-08
ATE250039T1 (de) 2003-10-15
IL148816A0 (en) 2002-09-12
AU774451B2 (en) 2004-06-24
IL148816A (en) 2006-10-31
ES2204704T3 (es) 2004-05-01
HUP0203142A2 (hu) 2003-02-28
JP3857138B2 (ja) 2006-12-13
RU2259360C2 (ru) 2005-08-27
EP1224174A2 (en) 2002-07-24
MA26831A1 (fr) 2004-12-20
WO2001029011A2 (en) 2001-04-26
HK1051038A1 (en) 2003-07-18
PL357418A1 (en) 2004-07-26
DE60005386T2 (de) 2004-06-24
NO20021690D0 (no) 2002-04-10
HUP0203142A3 (en) 2003-03-28
BR0014859A (pt) 2002-07-16
MY125540A (en) 2006-08-30
JP2003512359A (ja) 2003-04-02
SI1224174T1 (en) 2003-12-31
CZ20021653A3 (cs) 2002-08-14
NZ517999A (en) 2004-07-30
HRP20020259A2 (en) 2004-04-30
DE60005386D1 (de) 2003-10-23
NO327817B1 (no) 2009-09-28
AR026029A1 (es) 2002-12-26
YU26202A (sh) 2004-12-31
JO2262B1 (en) 2004-10-07
KR100480320B1 (ko) 2005-04-07
EP1224174B1 (en) 2003-09-17
CN1379765A (zh) 2002-11-13
KR20020038954A (ko) 2002-05-24
CO5261604A1 (es) 2003-03-31

Similar Documents

Publication Publication Date Title
TR200201023T2 (tr) Benzodiazepin türevleri.
TR200101893T2 (tr) Antiviral maddeler olarak 4-okso-1,4 dihidro -3- kuinolinkarboksamitler.
WO2006032466A3 (en) New bicyclic antibiotics
EA200300813A1 (ru) Огнезащитные реагенты
NZ507760A (en) Amide derivatives and nociceptin antagonists
EP1616864A4 (en) CHINOXALIN DERIVATIVES AND APPLIANCES MANUFACTURED BY THE DERIVATIVES USING ORGANIC SEMICONDUCTORS, ELECTROLUMINESCENT DEVICES AND ELECTRONIC EQUIPMENT
TR200102403T2 (tr) Piridopiranoazepin türevleri, bunların hazırlanmaları ve terapötik uygulamaları.
EP1000935A4 (en) PYRIDYLACRYLAMIDE DERIVATIVES, NEPHRITIS REMEDIES, AND TGF-BETA INHIBITORS CONTAINING THE SAME
DK0918776T3 (da) Totalsyntese af antitumor acylfulvener
EA200100310A1 (ru) Кислородсодержащие гетероциклические соединения
DE69818042D1 (de) Flüssige benzisochinoline derivate
MXPA03004036A (es) Derivados de pirimidina y herbicidas que los contienen.
DK1294705T3 (da) Syntese af cykliske forbindelser
DK1706414T3 (da) Fremgangsmåde til fluorcytidinderivater
TR200003652T2 (tr) Glisin antagonistleri olarak tetrahidrokuinolin türevleri.
BG101601A (en) Pharmaceutical piperazine compounds
DE69910568D1 (de) Furopyridinderivate und ihre therapeutische verwendung
CO5150201A1 (es) Derivados de piperidina
EA200400770A1 (ru) Производные 5-(пиридин-3-ил)-1-азабицикло[3.2.1]октана, их получение и применение в терапии
WO2004099130A3 (en) 1,2-diarylimidazoles useful as inhibitors of cox
EP1403268A4 (en) FLUORESCENT PROBES FOR ZINC
ATE181159T1 (de) Überbrückte photochrome verbindungen
UA80839C2 (en) 1-substituted 4-nitroimidazole compound and process for producing the same
FI903995A0 (fi) Imidazolyl- och pyridylderivat av fenylsubstituerade 1,4-dihydropyridiner och foerfarande foer framstaellning daerav.
DE60026161D1 (de) Amidin-derivate, ihre herstellung und verwendung als medikamenten